AIP
CRBU icon

Ameritas Investment Partners’s Caribou Biosciences CRBU Stock Holding History

Ameritas Investment Partners’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,487
Closed -$6.84K – 3231
2025
Q1 		$6.84K Hold
7,487
– – ﹤0.01% 2910
2024
Q4 		$11.9K Hold
7,487
– – ﹤0.01% 2855
2024
Q3 		$14.7K Hold
7,487
– – ﹤0.01% 2785
2024
Q2 		$12.3K Hold
7,487
– – ﹤0.01% 2847
2024
Q1 		$38.5K Hold
7,487
– – ﹤0.01% 2283
2023
Q4 		$42.9K Hold
7,487
– – ﹤0.01% 2256
2023
Q3 		$35.8K Buy
7,487
+3,542
+90% +$22K ﹤0.01% 2275
2023
Q2 		$16.8K Hold
3,945
– – ﹤0.01% 2650
2023
Q1 		$20.9K Hold
3,945
– – ﹤0.01% 2447
2022
Q4 		$25.4K Hold
3,945
– – ﹤0.01% 2456
2022
Q3 		$41K Hold
3,945
– – ﹤0.01% 2127
2022
Q2 		$21K Hold
3,945
– – ﹤0.01% 2522
2022
Q1 		$36K Buy
3,945
+2,475
+168% +$26.1K ﹤0.01% 2248
2021
Q4 		$22K Hold
1,470
– – ﹤0.01% 2594
2021
Q3 		$35K Buy
+1,470
New +$35.9K ﹤0.01% 2376

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameritas Investment Partners's CRBU Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Caribou Biosciences (CRBU) in Q2 2025, closing a stake of 7,487 shares — an estimated $6.84K sold.

Ameritas Investment Partners first reported a position in CRBU in Q3 2021 and held it in 15 quarters. The position peaked at $42.9K in Q4 2023. 129 funds tracked by Wall St. Rank hold CRBU as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Caribou Biosciences position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 7,487 Caribou Biosciences shares in Q2 2025, an estimated $6.84K.
  • Ameritas Investment Partners first reported a position in Caribou Biosciences in Q3 2021 and held it in 15 quarters.
  • Ameritas Investment Partners's Caribou Biosciences position peaked at $42.9K in Q4 2023.
  • 129 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.